Description
PHAP I Antibody | 3151 | Gentaur UK, US & Europe Distribution
Host: Rabbit
Reactivity: Human, Mouse, Rat
Homology: Predicted species reactivity based on immunogen sequence: Bovine: (85%)
Immunogen: Anti-PHAP I antibody (3151) was raised against a peptide corresponding to 14 amino acids near the carboxy terminus of human PHAP I .
The immunogen is located within the last 50 amino acids of PHAP I.
Research Area: Apoptosis
Tested Application: E, WB, IHC-P, IF
Application: WB: 1 μg/mL; IHC: 2 μg/mL; IF: 20 μg/mL.
Antibody validated: Western Blot in human, mouse and rat samples; Immunohistochemistry in mouse samples; Immunofluorescence in mouse samples. All other applications and species not yet tested.
Specificiy: This polyclonal antibody has no cross-reaction to PHAP I2a and PHAP III.
Positive Control 1: Cat. No. 1207 - Raji Cell Lysate
Positive Control 2: Cat. No. 1416 - Mouse Testis Tissue Lysate
Positive Control 3: Cat. No. 1476 - Rat Testis Tissue Lysate
Positive Control 4: Cat. No. 1408 - Mouse Small Intestine Tissue Lysate
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: Predicted: 29kD
Observed: 29 kD
Validation: N/A
Isoform: N/A
Purification: PHAP I Antibody is affinity chromatography purified via peptide column.
Clonality: Polyclonal
Clone: N/A
Isotype: IgG
Conjugate: Unconjugated
Physical State: Liquid
Buffer: PHAP I Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration: 1 mg/mL
Storage Condition: PHAP I antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Alternate Name: PHAP I Antibody: LANP, MAPM, PP32, HPPCn, PHAP1, PHAPI, I1PP2A, C15orf1, LANP, Acidic leucine-rich nuclear phosphoprotein 32 family member A, Acidic nuclear phosphoprotein pp32
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: PHAP I Antibody: Apoptosis is related to many diseases and development. Caspase-9 plays a central role in cell death induced by a variety of apoptosis activators. Cytochrome c, after released from mitochondria, binds to Apaf-1, which forms an apoptosome that in turn binds to and activate procaspase-9. Activated caspase-9 cleaves and activates the effector caspases (caspase-3, -6 and -7) , which are responsible for the proteolytic cleavage of many key proteins in apoptosis. The tumor suppressor putative HLA-DR-associated proteins (PHAPs) were recently identified as important regulators of mitochondrion apoptosis. PHAP appears to facilitate apoptosome-medicated caspase-9 activation and to stimulate the mitochondrial apoptotic pathway. PHAP was also shown to oppose both Ras- and Myc-medicated cell transformation.